Back

Complex ventricular arrhythmias are not associated with severity of mitral regurgitation in patients with arrhythmic mitral valve prolapse

31 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Nuclear cardiology innovations Inflammation, Infection, and Infiltrative Cardiovascular Disorders ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ravi Vazirani Ballesteros

San Carlos Clinical Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Evaluation of the 2024 European Society of Cardiology risk-factor and calcium score-weighted clinical likelihoods as gatekeeper for patients with suspected chronic coronary syndrome referred for PET
Doctor S. Frey (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic utility of quantitative positron emission tomography in patients with prior coronary artery bypass grafting: incremental value of myocardial flow reserve and coronary vascular resistance
Doctor Y. Kadoya (Ottawa, CA)
Abstract Slides Video
Presentation thumbnail
The role of Q-SPECT CT in identifying post-pulmonary embolism sequelae
Mrs G. Sorici (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
Prognostic factors in familial hypercholesterolemia : insights from NH3-PET imaging
Doctor A. Sakai (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Diagnosis and prognosis of coronary artery disease using artificial intelligence and nuclear cardiology: A systematic review
Doctor Y. Dai (Toronto, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Nuclear cardiology innovations

The Event

Event poster

ESC Congress 2025

31 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Ventricular arrhythmic severity using Lown and Wolf classification is correlated with a low metabolic activity on hybrid PET/MR in patients with mitral valve prolapse
thumbnail
Congress Presentation
Discussion - SAVE-MVP
thumbnail
Congress Presentation
Mitral valve prolapse: arrhythmic risk and prognosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources